ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $55,000 | -30.4% | 30,000 | 0.0% | 0.01% | -31.6% |
| Q2 2021 | $79,000 | -37.3% | 30,000 | -14.3% | 0.02% | -42.4% |
| Q1 2021 | $126,000 | -43.5% | 35,000 | -60.5% | 0.03% | -52.9% |
| Q4 2020 | $223,000 | -69.4% | 88,525 | -69.4% | 0.07% | -73.6% |
| Q3 2020 | $728,000 | -4.1% | 289,025 | +24.6% | 0.26% | -7.0% |
| Q2 2020 | $759,000 | +34.3% | 232,025 | +0.7% | 0.28% | +9.6% |
| Q1 2020 | $565,000 | -75.4% | 230,525 | -52.6% | 0.26% | -39.4% |
| Q4 2019 | $2,294,000 | +122.5% | 486,050 | +101.8% | 0.43% | -7.3% |
| Q3 2019 | $1,031,000 | -18.5% | 240,800 | +11.0% | 0.46% | -19.9% |
| Q2 2019 | $1,265,000 | +64.3% | 216,950 | +8.5% | 0.58% | +55.8% |
| Q1 2019 | $770,000 | +118.1% | 199,950 | +5.8% | 0.37% | +71.0% |
| Q4 2018 | $353,000 | – | 188,950 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 17,815,708 | $47,033,000 | 2.93% |
| Essex Woodlands Management, Inc. | 2,764,908 | $7,130,000 | 2.60% |
| Belmont Global Advisors, Inc. | 973,000 | $2,569,000 | 2.01% |
| Belmont Global Advisors, Inc. | 135,700 | $358,000 | 0.28% |
| MSD Partners, L.P. | 2,750,000 | $7,260,000 | 0.22% |
| SFMG, LLC | 99,850 | $264,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,090 | $29,000 | 0.03% |
| WESTPORT RESOURCES MANAGEMENT INC | 33,500 | $88,000 | 0.02% |
| SMITH ASSET MANAGEMENT GROUP LP | 236,590 | $625,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 41,150 | $109,000 | 0.02% |